METAB-HTX: Prospective, Longitudinal Cohort Study Evaluationg Cardiac and Systemic Metabolism After Heart Transplantation
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age: ≥ 18 years
• Planned or already conducted heart transplantation
• Informed consent
Locations
Other Locations
Germany
University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology
RECRUITING
Düsseldorf
Contact Information
Primary
Amin Polzin, Prof.
amin.polzin@med.uni-duesseldorf.de
0211 81 18801
Backup
Fabian Voß, Dr. med.
fabian.voss@med.uni-duesseldorf.de
02118118800
Time Frame
Start Date: 2025-07-24
Estimated Completion Date: 2032-02-01
Participants
Target number of participants: 270
Treatments
Adult advanced heart failure patients listed for HTx
Patients with advanced heat failure (AHF) and listed for heart transplantation (HTx)
Related Therapeutic Areas
Sponsors
Leads: Heinrich-Heine University, Duesseldorf